The United States is in the midst of a crisis of suicide, and TMS providers often must confront this directly. In this presentation, Dr. Philip will provide a brief overview of the existing TMS protocols used to reduce suicidal ideation, reviewing their efficacy and also burden of administration. He will describe an ongoing clinical trial combining TMS plus psychotherapy for PTSD, and outline his own clinical approach to treating suicidal patients, so that attendees can consider how they can address this critically important issue.
At the end of the presentation, attendees will be able to:
- Describe various evidence-based TMS parameters to treating patients at higher suicide risk.
- Demonstrate understanding of the interaction (or lack thereof) between changes in depression and suicidal ideation during TMS.
- Discuss future TMS options in high risk patients.
Format: On-Demand Webinar
Cost: Members: $25 | Non-members $50 | Student Members FREE
Speaker: Noah S. Philip, MD
Dr. Philip is a Professor of Psychiatry and Human Behavior at the Alpert Medical School of Brown University. He is the founding Section Chief of Psychiatric Neuromodulation at VA Providence, and is Lead for Mental Health Research at the VA RR&D Center for Neurorestoration and Neurotechnology.
Dr. Philip received his BSc from McGill University and his MD from Albany Medical College where he graduated AOA and with a Distinction in the Study of Biomedical Ethics. He completed his psychiatry residency training at Brown University, followed by T32 and Neuromodulation Fellowships at Brown.
Dr. Philip’s laboratory uses a precision approach to new and emerging technologies, with the goal to understand and treat posttraumatic stress disorder, major depression, and suicidality. His research has been featured in JAMA Psychiatry, American Journal of Psychiatry, Biological Psychiatry, and the National Neuroscience Curriculum Initiative (tDCS+Virtual Reality for PTSD). He is currently conducting an NIMH-funded cooperative study to perform a first-in-human study investigating MRI-guided low intensity focused ultrasound for depression and anxiety (U01 MH123427).
Dr. Philip has received awards and recognition from the American Psychiatric Association, Society for Biological Psychiatry, American College of Neuropsychopharmacology, and others. He has been funded through grants from the VA (Rehabilitation, Clinical Science, and Health Services R&D), NIMH, NIDA, Department of Defense, and through industry and small-business collaborations. He is active in several national organizations, including SOBP and ACNP, and is a past President of the Psychiatric Research Society.
Dr. Philip plays a significant training and mentoring role at Brown, where he is Associate Director of the NIMH R25 psychiatry resident research training program, and serves as a mentor through national organizations such as the Career Development Institute for Psychiatry. He is committed to action to improve diversity, equity, inclusion, and belonging.